ISSN: 2454-2342 (online), 2454-2334 (print)
Note: All contents are under the terms of Creative Commons (CC BY-NC-SA 4.0) International License.

The New Indian Journal of OBGYN. 12(1):3-12

Oncofertility: navigating fertility challenges and preservation options for female cancer survivors

Tarini Sonwani, Arunima Halder

ABSTRACT

Oncofertility is an evolving field that bridges oncology and reproductive health, addressing the reproductive challenges faced by cancer patients. With significant improvements in cancer survival rates, there is a growing emphasis on fertility preservation for both men and women undergoing cancer treatment. Additionally, societal trends over the past forty years show an increasing delay in childbearing, contributing to a rise in infertility cases among cancer survivors. Many couples are now seeking help from reproductive medicine specialists after one partner has completed cancer therapy. In most instances, infertility is a consequence of treatments such as chemotherapy, radiotherapy, or surgical interventions. This review explores how these cancer therapies impact female fertility and examines the current fertility preservation methods available, assessing their effectiveness in terms of achieving pregnancies and live births.

doi: 10.21276/obgyn.2025.v12.i1.02 Full Text PDF
new link for FULL TEXT PDF
About
About Journal
Aim & Scope
Editorial Board
Copyright Policy
Plagiarism Prevention
Review Process
Peer Reviewers
Indexed / Listed in:
DOAJ
Archives
Volume 1 Issue 1
Volume 1 Issue 2
Volume 2 Issue 1
Volume 2 Issue 2
Volume 3 Issue 1
Volume 3 Issue 2
Volume 4 Issue 1
Volume 4 Issue 2
Volume 5 Issue 1
Volume 5 Issue 2
Volume 6 Issue 1
Volume 6 Issue 2
Volume 7 Issue 1
Volume 7 Issue 2
Volume 8 Issue 1
Volume 8 Issue 2
Volume 9 Issue 1
Volume 9 Issue 2
Volume 10 Issue 1
Volume 10 Issue 2
Volume 11 Issue 1
Volume 11 Issue 2
Volume 12 Issue 1
Volume 12 Issue 2
For Authors
Author Instructions
Submit your article to: barpetaogs@gmail.com
Article Status
Creative Commons License
This work is licensed under a CC BY-NC-SA 4.0. Attribution-NonCommercial-ShareAlike 4.0 International License.